Search Results 651-660 of 18307 for prostate cancer
Giving CJNJ-67652000 and prednisone may kill more tumor cells in patients with metastatic prostate cancer than giving these drugs alone. Participation ...
Positron Emission Tomography Using 64Cu-SAR-bisPSMA In Participants With High-risk Prostate Cancer Prior To Radical Prostatectomy · Share · Facebook · Twitter.
Castration-resistant prostate cancer patients with rising prostatic specific antigen (PSA) are eligible for this study. 11C-Choline PET/CT will be used to ...
... prostate cancer treatment compared to other minority groups. The study was recently published in Mayo Clinic Proceedings. Researchers say that it has long ...
Young works to discover genes that may be used as tools for the detection and treatment of prostate cancer. Focus areas. Growth and differentiation of prostatic ...
Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer. While those findings are only preliminary, several clinical ...
Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.
Prostate MRI. In the U.S., prostate cancer is the most common and second-most deadly noncutaneous cancer in men. But five-year survival rates approaching 100 ...
The purpose of this study is to investigate whether malignant prostate cancer cells can be identified in seminal fluid expressed during the course of ...
This phase II pilot trial studies how well bicalutamide and raloxifene hydrochloride work in treating patients with prostate cancer undergoing surgery.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.